Search

Dupilumab was approved for treating moderate to severe atopic dermatitis (AD). However, a notable subset of patients remains unresponsive and factors associated with dupilumab response remain limited.

Exercise-induced bronchospasm (EIB) commonly coexists with asthma. However, the data on the efficacy of maintenance therapies for asthma with EIB are scarce.

A maintenance oral corticosteroid (OCS) in addition to high-dose inhaled corticosteroids plus long-acting β2-agonists in patients with severe asthma leads to long-term adverse events. Oral corticosteroid–sparing agents are of high priority.

Anaphylaxis in hospitalized patients has been infrequently reviewed. There are few studies of anaphylaxis from Asian countries.

House dust mite sublingual immunotherapy (HDM SLIT) effectively treats allergic rhinitis (AR). However, the evidence of HDM SLIT for allergic asthma remained limited.

Using intranasal corticosteroid (INCS) regularly is recommended for treating perennial allergic rhinitis. However, no studies have evaluated “as-needed” use.

Primary osteoarthritis of the sternoclavicular joint SCJ is relatively common, occurring in 90 of people over age 60, and must be considered in the differential of chest wall pain. Lesions typically appear after age 40 years and are either bilateral or slightly more common in the SCJ of the dominant hand. Diagnosis by plain xrays is confounded by overlapping structures therefore SCJ osteoarthritis is most easily diagnosed by classic radiographic findings on computed tomography of the sternoclavicular joint. Treatment consists of rest, physical therapy, nonsteroidal antiinflammatory drugs, or local corticosteroid injection, with surgery for those with intractable pain.